β2AR activation suppresses immune surveillance by reducing the proliferation and activation of CD8+ T cells, leading to T cell exhaustion, and driving macrophages towards a tumour‐promoting M2 phenotype [29, 30, 31, 32]. The gene discussed is ADRB2; the disease is neoplasm.